| [1] | World Health Organisation, "Global report on diabetes", 2018. |
| |
| [2] | M. Virally, J. F. Blicklé, J. Girard, S. Halimi, D. Simon, and P. J. Guillausseau, "Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives", Diabetes Metab., vol. 33, no. 4, pp. 231–244, 2007. |
| |
| [3] | A. D. von Frankenberg, A. Marina, X. Song, H. S. Callahan, M. Kratz, and K. M. Utzschneider, "A high-fat, high-saturated fat diet decreases insulin sensitivity without changing intra-abdominal fat in weight-stable overweight and obese adults", Eur. J. Nutr., vol. 56, no. 1, pp. 431-443, 2017. |
| |
| [4] | K. Blaslov, F. S. Naranđa, I. Kruljac, and I. P. Renar, "Treatment approach to type 2 diabetes: Past, present and future", World J. Diabetes, vol. 9, no. 12, pp. 209-219, 2018. |
| |
| [5] | W. C. Yeh, Y. C. Tsao, W. C. Li, I. S. Tzeng, L. S. Chen, and J. Y. Chen, "Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: A cross-sectional study", Lipids Health Dis., vol. 18, no. 1, pp. 1-7, 2019. |
| |
| [6] | E. G. Behiry, N. M. El Nady, O. M. AbdEl Haie, M. K. Mattar, and A. Magdy, “Evaluation of TG-HDL Ratio Instead of HOMA Ratio as Insulin Resistance Marker in Overweight and Children with Obesity”, Endocrine, Metab. Immune Disord. - Drug Targets, vol. 19, no. 5, pp. 676-682, 2019. |
| |
| [7] | B. Pantoja-Torres et al., “High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults”, Diabetes Metab. Syndr. Clin. Res. Rev., vol. 13, no. 1, pp. 382-388, 2019. |
| |
| [8] | V. Mani and L. C. Ming, “Tempeh and Other Fermented Soybean Products Rich in Isoflavones”, in Fermented Foods in Health and Disease Prevention, Elsevier Inc., 2017, pp. 453-474. |
| |
| [9] | D. Y. Kwon, J. W. Daily, H. J. Kim, and S. Park, “Antidiabetic effects of fermented soybean products on type 2 diabetes”, Nutr. Res., vol. 30, no. 1, pp. 1-13, 2010. |
| |
| [10] | M. Jayachandran and B. Xu, "An insight into the health benefits of fermented soy products", Food Chem., vol. 271, no. July, pp. 362-371, 2019. |
| |
| [11] | S. Oh et al., "Ginger extract increases muscle mitochondrial biogenesis and serum HDL-cholesterol level in high-fat diet-fed rats", J. Funct. Foods, vol. 29, pp. 193-200, 2017. |
| |
| [12] | A. M. Al Hroob, M. H. Abukhalil, R. D. Alghonmeen, and A. M. Mahmoud, "Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy", Biomed. Pharmacother., vol. 106, no. June, pp. 381-389, 2018. |
| |
| [13] | A. Vilela, “The importance of yeasts on fermentation quality and human health-promoting compounds”, Fermentation, vol. 5, no. 2, 2019. |
| |
| [14] | Z. H. Cao, J. M. Green-Johnson, N. D. Buckley, and Q. Y. Lin, “Bioactivity of soy-based fermented foods: A review”, Biotechnol. Adv., vol. 37, no. 1, pp. 223-238, 2019. |
| |
| [15] | X. Meng et al., "Dietary sources and bioactivities of melatonin", Nutrients, vol. 9, no. 4, pp. 1-64, 2017. |
| |
| [16] | T. da S. M. de Farias et al., "Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice", Front. Endocrinol. (Lausanne)., vol. 10, no. November, pp. 1-13, 2019. |
| |
| [17] | S. H. Bintari, N. D. Putriningtyas, K. Nugraheni, N. S. Widyastiti, E. Dharmana, and A. Johan, “Comparative effect of Tempe and soymilk on fasting blood glucose, insulin level and pancreatic beta cell expression (Study on streptozotocin-lnduced diabetic rats)”, Pakistan Journal of Nutrition, vol. 14, no. 4. pp. 239-246, 2015. |
| |
| [18] | M. H. El Gayar, M. M. M. Aboromia, N. A. Ibrahim, and M. H. Abdel Hafiz, "Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus", Obes. Med., vol. 14, no. April, 2019. |
| |
| [19] | J. Zhu, H. Chen, Z. Song, X. Wang, and Z. Sun, "Effects of Ginger (Zingiber officinale Roscoe) on Type 2 Diabetes Mellitus and Components of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials", Evidence-based Complement. Altern. Med., vol. 2018, 2018. |
| |
| [20] | C. K. Wei et al., "6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice", Int. J. Mol. Sci., vol. 18, no. 1, pp. 1-18, 2017. |
| |
| [21] | A. Saedisomeolia et al., “Mechanisms of action of ginger in nuclear factor-kappaB signaling pathways in diabetes”, J. Herb. Med., vol. 16, 2019. |
| |
| [22] | Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, “Gingerols of zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes”, Planta Med., vol. 78, no. 14, pp. 1549-1555, 2012. |
| |
| [23] | Y. Isa et al., “6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes”, Biochem. Biophys. Res. Commun., vol. 373, no. 3, pp. 429-434, 2008. |
| |